IMP
Process View
negative regulation of t cell apoptotic process
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell death by apoptotic process.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of t cell apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.994 | ||
| PRKCZ | protein kinase C, zeta | 0.992 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.986 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.960 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.849 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.801 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.764 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.763 | Mouse | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.720 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.706 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.664 | Human | |
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.653 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.652 | Human | |
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.567 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.556 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.520 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.512 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.487 | ||
| NUMB | numb homolog (Drosophila) | 0.477 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.477 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.443 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.414 | Human | |
| IL32 | interleukin 32 | 0.391 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.358 | Human | |
| ZNF71 | zinc finger protein 71 | 0.351 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.349 | ||
| IDE | insulin-degrading enzyme | 0.320 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.312 | ||
| CREBBP | CREB binding protein | 0.306 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.286 | Mouse | |
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.272 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.256 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.253 | ||
| FSTL1 | follistatin-like 1 | 0.253 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.225 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.224 | Human | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.218 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.212 | Human | |
| BRCA1 | breast cancer 1, early onset | 0.207 | ||
| PRKCB | protein kinase C, beta | 0.193 | ||
| IL8 | interleukin 8 | 0.192 | ||
| TOP3A | topoisomerase (DNA) III alpha | 0.171 | ||
| IL1B | interleukin 1, beta | 0.169 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.160 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.145 | ||
| TRIM9 | tripartite motif containing 9 | 0.144 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.143 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.142 | ||
| ARRB1 | arrestin, beta 1 | 0.129 | ||
| CDCP1 | CUB domain containing protein 1 | 0.128 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.127 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.110 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.109 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.107 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.107 | ||
| BID | BH3 interacting domain death agonist | 0.106 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.106 | ||
| CRLF3 | cytokine receptor-like factor 3 | 0.105 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.102 | ||
| GLI1 | GLI family zinc finger 1 | 0.102 | ||
| GLRX3 | glutaredoxin 3 | 0.098 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.095 | Human | |
| HPCAL4 | hippocalcin like 4 | 0.095 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.094 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.093 | Human | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.093 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.092 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.087 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.084 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.083 | ||
| DAXX | death-domain associated protein | 0.082 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.080 | ||
| LRCH1 | leucine-rich repeats and calponin homology (CH) domain containing 1 | 0.080 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.079 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.079 | ||
| RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0.079 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.077 | ||
| SELE | selectin E | 0.076 | ||
| CD83 | CD83 molecule | 0.074 | ||
| TNF | tumor necrosis factor | 0.071 | ||
| DARC | Duffy blood group, chemokine receptor | 0.070 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.069 | ||
| IL7R | interleukin 7 receptor | 0.068 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.068 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.067 | ||
| SMAD3 | SMAD family member 3 | 0.065 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.065 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.065 | ||
| NMT2 | N-myristoyltransferase 2 | 0.064 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.064 | ||
| ATM | ataxia telangiectasia mutated | 0.063 | ||
| ZHX1 | zinc fingers and homeoboxes 1 | 0.061 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.060 | ||
| WRN | Werner syndrome, RecQ helicase-like | 0.059 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.058 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.056 | ||
| DCTN1 | dynactin 1 | 0.056 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.056 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.056 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.054 | ||
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.052 | ||
| IL10 | interleukin 10 | 0.050 | ||
| GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.050 | ||
| NOG | noggin | 0.049 | ||
| GNLY | granulysin | 0.048 | ||
| RAD52 | RAD52 homolog (S. cerevisiae) | 0.047 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.046 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.046 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.046 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.045 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.045 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.044 | ||
| XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | 0.042 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.041 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.041 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.041 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.040 | ||
| POFUT1 | protein O-fucosyltransferase 1 | 0.040 | ||
| MANF | mesencephalic astrocyte-derived neurotrophic factor | 0.039 | ||
| HIF1AN | hypoxia inducible factor 1, alpha subunit inhibitor | 0.038 | ||
| GLA | galactosidase, alpha | 0.038 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.037 | ||
| MAPT | microtubule-associated protein tau | 0.037 | ||
| CCHCR1 | coiled-coil alpha-helical rod protein 1 | 0.036 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.035 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.035 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.034 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.033 | ||
| CH25H | cholesterol 25-hydroxylase | 0.033 | ||
| PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 | 0.033 | ||
| CCDC117 | coiled-coil domain containing 117 | 0.033 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.033 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.032 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.032 | Human | |
| F11R | F11 receptor | 0.032 | ||
| IL2RB | interleukin 2 receptor, beta | 0.031 | ||
| EP300 | E1A binding protein p300 | 0.031 | ||
| SETDB1 | SET domain, bifurcated 1 | 0.031 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.030 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.030 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.030 | ||
| SH2D1A | SH2 domain containing 1A | 0.030 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.030 | ||
| SP1 | Sp1 transcription factor | 0.030 | ||
| LDLR | low density lipoprotein receptor | 0.029 | ||
| SPRR2A | small proline-rich protein 2A | 0.029 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.029 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.029 | Human | |
| CD163 | CD163 molecule | 0.029 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.029 | ||
| TSC2 | tuberous sclerosis 2 | 0.028 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.028 | ||
| TUBB2C | tubulin, beta 2C | 0.028 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.028 | ||
| FPR3 | formyl peptide receptor 3 | 0.027 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.027 | ||
| SAMD4B | sterile alpha motif domain containing 4B | 0.027 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.027 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.027 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.026 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.026 | ||
| MSC | musculin | 0.026 | ||
| TXNIP | thioredoxin interacting protein | 0.026 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.026 | ||
| BCL2A1 | BCL2-related protein A1 | 0.026 | ||
| TERF2 | telomeric repeat binding factor 2 | 0.026 | ||
| RB1 | retinoblastoma 1 | 0.025 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.025 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.025 | ||
| APOC1 | apolipoprotein C-I | 0.025 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.025 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.025 | ||
| IL1A | interleukin 1, alpha | 0.025 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.025 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.025 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.024 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.024 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.024 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.024 | ||
| IL21R | interleukin 21 receptor | 0.023 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.023 | ||
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.023 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.023 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.023 | Human | |
| RGS16 | regulator of G-protein signaling 16 | 0.023 | ||
| IFNG | interferon, gamma | 0.023 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.023 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.023 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.022 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.022 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.022 | ||
| LRCH3 | leucine-rich repeats and calponin homology (CH) domain containing 3 | 0.022 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.021 | ||
| BAD | BCL2-associated agonist of cell death | 0.021 | ||
| SYK | spleen tyrosine kinase | 0.021 | ||
| BMP2 | bone morphogenetic protein 2 | 0.021 | Human | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.021 | ||
| SQSTM1 | sequestosome 1 | 0.020 | ||
| WWC1 | WW and C2 domain containing 1 | 0.020 | ||
| C16orf75 | chromosome 16 open reading frame 75 | 0.020 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.020 | ||
| EGLN2 | egl nine homolog 2 (C. elegans) | 0.020 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.020 | ||
| GCH1 | GTP cyclohydrolase 1 | 0.020 | ||
| PIM2 | pim-2 oncogene | 0.019 | ||
| BTBD2 | BTB (POZ) domain containing 2 | 0.019 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.019 | ||
| VIM | vimentin | 0.019 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.019 | ||
| SRI | sorcin | 0.019 | ||
| INHBA | inhibin, beta A | 0.019 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.019 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.019 | ||
| DENND5A | DENN/MADD domain containing 5A | 0.019 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.019 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.019 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.019 | ||
| MUS81 | MUS81 endonuclease homolog (S. cerevisiae) | 0.019 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.019 | ||
| CTSW | cathepsin W | 0.019 | ||
| IL4R | interleukin 4 receptor | 0.018 | ||
| BCL2L1 | BCL2-like 1 | 0.018 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.018 | ||
| FOXO3 | forkhead box O3 | 0.018 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.018 | ||
| THEM4 | thioesterase superfamily member 4 | 0.018 | ||
| CUL2 | cullin 2 | 0.018 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.018 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.018 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.018 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.018 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.018 | ||
| SEPT9 | septin 9 | 0.018 | ||
| LRCH2 | leucine-rich repeats and calponin homology (CH) domain containing 2 | 0.018 | ||
| FANCE | Fanconi anemia, complementation group E | 0.018 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.017 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.017 | ||
| ASXL1 | additional sex combs like 1 (Drosophila) | 0.017 | ||
| IRF4 | interferon regulatory factor 4 | 0.017 | ||
| CNTF | ciliary neurotrophic factor | 0.017 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.017 | ||
| MBD4 | methyl-CpG binding domain protein 4 | 0.017 | ||
| MTA1 | metastasis associated 1 | 0.017 | ||
| PDPN | podoplanin | 0.017 | ||
| SH2D2A | SH2 domain containing 2A | 0.017 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.017 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.017 | ||
| STK4 | serine/threonine kinase 4 | 0.017 | ||
| ACTB | actin, beta | 0.017 | ||
| FOXO1 | forkhead box O1 | 0.017 | ||
| CHI3L2 | chitinase 3-like 2 | 0.016 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.016 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.016 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.016 | ||
| GATAD2B | GATA zinc finger domain containing 2B | 0.016 | ||
| UBD | ubiquitin D | 0.016 | ||
| PKD1L3 | polycystic kidney disease 1-like 3 | 0.016 | ||
| GPR109B | G protein-coupled receptor 109B | 0.016 | ||
| PNMA1 | paraneoplastic antigen MA1 | 0.016 | ||
| CTTNBP2NL | CTTNBP2 N-terminal like | 0.016 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.016 | ||
| NNMT | nicotinamide N-methyltransferase | 0.016 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.016 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.016 | ||
| SLMAP | sarcolemma associated protein | 0.016 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.016 | ||
| TLR2 | toll-like receptor 2 | 0.016 | ||
| LMO4 | LIM domain only 4 | 0.016 | ||
| DOCK6 | dedicator of cytokinesis 6 | 0.016 | ||
| CD6 | CD6 molecule | 0.016 | ||
| DGKI | diacylglycerol kinase, iota | 0.016 | ||
| C19orf39 | chromosome 19 open reading frame 39 | 0.015 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.015 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.015 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.015 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.015 | ||
| PIK3IP1 | phosphoinositide-3-kinase interacting protein 1 | 0.015 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.015 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.015 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.015 | ||
| CD5 | CD5 molecule | 0.015 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.015 | ||
| CD247 | CD247 molecule | 0.015 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.015 | ||
| CRMP1 | collapsin response mediator protein 1 | 0.015 | ||
| RIF1 | RAP1 interacting factor homolog (yeast) | 0.015 | ||
| C5AR1 | complement component 5a receptor 1 | 0.015 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.015 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.015 | ||
| CCBP2 | chemokine binding protein 2 | 0.015 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.015 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.015 | ||
| FAM129A | family with sequence similarity 129, member A | 0.015 | ||
| IGK@ | immunoglobulin kappa locus | 0.015 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.015 | ||
| CHSY1 | chondroitin sulfate synthase 1 | 0.015 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.015 | ||
| IGL@ | immunoglobulin lambda locus | 0.014 | ||
| HTT | huntingtin | 0.014 | ||
| CD4 | CD4 molecule | 0.014 | ||
| CD69 | CD69 molecule | 0.014 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.014 | ||
| OSM | oncostatin M | 0.014 | ||
| MOBKL1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 0.014 | ||
| FANCM | Fanconi anemia, complementation group M | 0.014 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.014 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.014 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.014 | ||
| BDKRB1 | bradykinin receptor B1 | 0.014 | ||
| SRGN | serglycin | 0.014 | ||
| PLEK | pleckstrin | 0.014 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.014 | ||
| BMP4 | bone morphogenetic protein 4 | 0.014 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.014 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.014 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.014 | ||
| PKM2 | pyruvate kinase, muscle | 0.014 | ||
| NOP10 | NOP10 ribonucleoprotein homolog (yeast) | 0.014 | ||
| MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | 0.014 | ||
| PPP1R10 | protein phosphatase 1, regulatory (inhibitor) subunit 10 | 0.014 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.013 | ||
| ZNF33B | zinc finger protein 33B | 0.013 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.013 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.013 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.013 | ||
| EDN1 | endothelin 1 | 0.013 | ||
| SESN2 | sestrin 2 | 0.013 | ||
| RHEBL1 | Ras homolog enriched in brain like 1 | 0.013 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.013 | ||
| RUNX1 | runt-related transcription factor 1 | 0.013 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.013 | ||
| ADAP1 | ArfGAP with dual PH domains 1 | 0.013 | ||
| RAD51L1 | RAD51-like 1 (S. cerevisiae) | 0.013 | ||
| TAGLN2 | transgelin 2 | 0.013 | ||
| AR | androgen receptor | 0.013 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.013 | ||
| TRPC1 | transient receptor potential cation channel, subfamily C, member 1 | 0.013 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.013 | ||
| CD72 | CD72 molecule | 0.013 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.013 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.013 | ||
| HSF1 | heat shock transcription factor 1 | 0.013 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.013 | ||
| SLC7A5 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 | 0.012 | ||
| CD160 | CD160 molecule | 0.012 | ||
| SMAD2 | SMAD family member 2 | 0.012 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.012 | ||
| MED25 | mediator complex subunit 25 | 0.012 | ||
| TNC | tenascin C | 0.012 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.012 | ||
| STK38L | serine/threonine kinase 38 like | 0.012 | ||
| TIAF1 | TGFB1-induced anti-apoptotic factor 1 | 0.012 | ||
| BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.012 | ||
| P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.012 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.012 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.012 | ||
| APOA1 | apolipoprotein A-I | 0.012 | ||
| CST7 | cystatin F (leukocystatin) | 0.012 | ||
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.012 | ||
| AQP9 | aquaporin 9 | 0.012 | ||
| KYNU | kynureninase | 0.012 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.012 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.012 | ||
| PASK | PAS domain containing serine/threonine kinase | 0.012 | ||
| OS9 | osteosarcoma amplified 9, endoplasmic reticulum lectin | 0.012 | ||
| DENND2D | DENN/MADD domain containing 2D | 0.012 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.012 | ||
| DPT | dermatopontin | 0.012 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.012 | ||
| HDAC1 | histone deacetylase 1 | 0.012 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.012 | ||
| TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 | 0.012 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.012 | ||
| AHR | aryl hydrocarbon receptor | 0.012 | ||
| HS3ST1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 0.012 | ||
| TPSB2 | tryptase beta 2 (gene/pseudogene) | 0.011 | ||
| CTRL | chymotrypsin-like | 0.011 | ||
| SLC43A3 | solute carrier family 43, member 3 | 0.011 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.011 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.011 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.011 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.011 | ||
| ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) | 0.011 | ||
| SIAH2 | seven in absentia homolog 2 (Drosophila) | 0.011 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.011 | ||
| TCL1A | T-cell leukemia/lymphoma 1A | 0.011 | ||
| POU2AF1 | POU class 2 associating factor 1 | 0.011 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.011 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.011 | ||
| RAG2 | recombination activating gene 2 | 0.011 | ||
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 0.011 | ||
| SEPT11 | septin 11 | 0.011 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.011 | ||
| CNN1 | calponin 1, basic, smooth muscle | 0.011 | ||
| FAM20C | family with sequence similarity 20, member C | 0.011 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.011 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.011 | ||
| SCARF1 | scavenger receptor class F, member 1 | 0.011 | ||
| CD48 | CD48 molecule | 0.011 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.011 | ||
| MARCO | macrophage receptor with collagenous structure | 0.011 | ||
| ATXN7L3 | ataxin 7-like 3 | 0.011 | ||
| PNPLA3 | patatin-like phospholipase domain containing 3 | 0.011 | ||
| ITGB7 | integrin, beta 7 | 0.011 | ||
| TXK | TXK tyrosine kinase | 0.011 | ||
| HAPLN3 | hyaluronan and proteoglycan link protein 3 | 0.011 | ||
| TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.011 | ||
| LGMN | legumain | 0.011 | ||
| HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B | 0.011 | ||
| CTBP1 | C-terminal binding protein 1 | 0.011 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.011 | ||
| C3 | complement component 3 | 0.011 | ||
| AQP3 | aquaporin 3 (Gill blood group) | 0.011 | ||
| BMP6 | bone morphogenetic protein 6 | 0.011 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.011 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.011 | ||
| CD40LG | CD40 ligand | 0.011 | ||
| PTX3 | pentraxin 3, long | 0.011 | ||
| HAS2 | hyaluronan synthase 2 | 0.011 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.011 | ||
| SLC25A19 | solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19 | 0.011 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.011 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.011 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.010 | ||
| C2 | complement component 2 | 0.010 | ||
| CCR10 | chemokine (C-C motif) receptor 10 | 0.010 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.010 | ||
| TTR | transthyretin | 0.010 | ||
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.010 | ||
| MTHFD1 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase | 0.010 | ||
| SLAMF8 | SLAM family member 8 | 0.010 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.010 | ||
| FLOT2 | flotillin 2 | 0.010 | ||
| NKG7 | natural killer cell group 7 sequence | 0.010 | ||
| LAT | linker for activation of T cells | 0.010 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.010 | ||
| FMO1 | flavin containing monooxygenase 1 | 0.010 | ||
| RASGRP3 | RAS guanyl releasing protein 3 (calcium and DAG-regulated) | 0.010 | ||
| TYMP | thymidine phosphorylase | 0.010 | ||
| IL11 | interleukin 11 | 0.010 | ||
| PRAME | preferentially expressed antigen in melanoma | 0.010 | ||
| FST | follistatin | 0.010 | ||
| PRKCA | protein kinase C, alpha | 0.010 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.010 | ||
| UCP2 | uncoupling protein 2 (mitochondrial, proton carrier) | 0.010 | ||
| PIM1 | pim-1 oncogene | 0.010 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.010 | ||
| SAA2 | serum amyloid A2 | 0.010 | ||
| PTGES | prostaglandin E synthase | 0.010 | ||
| CP | ceruloplasmin (ferroxidase) | 0.010 | ||
| CCDC82 | coiled-coil domain containing 82 | 0.010 | ||
| BDKRB2 | bradykinin receptor B2 | 0.010 | ||
| C10orf10 | chromosome 10 open reading frame 10 | 0.010 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.010 |